KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Long-Term Investments (2017 - 2026)

Moderna (MRNA) has disclosed Long-Term Investments for 10 consecutive years, with $2.3 billion as the latest value for Q1 2026.

  • For Q1 2026, Long-Term Investments fell 6.91% year-over-year to $2.3 billion; the TTM value through Mar 2026 reached $2.3 billion, down 6.91%, while the annual FY2025 figure was $2.3 billion, 6.34% down from the prior year.
  • Long-Term Investments hit $2.3 billion in Q1 2026 for Moderna, down from $2.3 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $10.2 billion in Q2 2022 and bottomed at $36.0 million in Q1 2023.
  • Average Long-Term Investments over 5 years is $4.4 billion, with a median of $2.5 billion recorded in 2024.
  • Year-over-year, Long-Term Investments crashed 99.61% in 2023 and then surged 10005.56% in 2024.
  • Moderna's Long-Term Investments stood at $8.3 billion in 2022, then plummeted by 43.77% to $4.7 billion in 2023, then crashed by 46.68% to $2.5 billion in 2024, then fell by 6.34% to $2.3 billion in 2025, then decreased by 3.64% to $2.3 billion in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $2.3 billion, $2.3 billion, and $2.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.